High autophagic flux guards ESC identity through coordinating autophagy machinery gene program by FOXO1
Lancet Diabetes Endocrinol 3(5):367381 van Bommel EJM, Muskiet MHA, Tonneijck L, Kramer MHH, Nieuwdorp M, van Raalte DH (2017) SGLT2 inhibition in the diabetic kidneyfrom mechanisms to clinical outcome
Some of the best fat loss peptides are promising in clinical settings, particularly GLP-1 agonists like semaglutide
Just as important as choosing the right medication is ensuring that the medication is safe, properly manufactured, and clinically validated
This post is for those currently using GLP-1 medications, those curious about them, and those who may want to support GLP-1 activation naturally